We Can Fix What's Broken in Research—If We Solve the Right Problems

The clinical research industry faces persistent challenges in patient recruitment and trial participation, despite significant investments in AI tools and targeted advertisements. Enrollment rates remain stagnant due to systemic barriers such as restrictive protocol designs, inadequate patient compensation, and cumbersome logistics, which deter diverse patient participation. These issues lead to under-enrollment, biased data, and delays in the development and approval of new therapies. Key strategies for overcoming these issues include managing travel logistics, simplifying reimbursement processes, and offering multilingual support to accommodate a diverse patient population.

By addressing these fundamental barriers, Scout Clinical aims to make clinical trials more accessible and appealing to potential participants, thereby enhancing recruitment efforts and fostering long-term trust and engagement in the clinical research process. Learn more about they the clinical research industry should focus on these critical areas to ensure successful trial outcomes and expedite the delivery of new therapies to market.